Switching FDA U.S. Agents After a Missed Renewal or Bad Service

When to use this playbook

Your current U.S. Agent forwards mail but does not manage renewals, registration updates, or product-listing upkeep.
You missed a renewal window, nearly missed one, or found out about an FDA notice later than you should have.
You are approaching the next annual or biennial renewal and want to switch agents without creating a registration gap.
You need a service model that handles the filing mechanics as well as the point-of-contact role.

The buyer question here is not whether you need a U.S. Agent. You already know that. The real question is whether your current provider is only satisfying the minimum contact-field requirement while leaving the operational risk with you.

That distinction matters because FDA systems treat the U.S. Agent as part of the registration record for foreign facilities in multiple verticals, and some systems require the new agent to affirm consent before the update is complete. For device establishments, FDA says the designated U.S. Agent must confirm electronically, and if the agent does not respond within 10 business days, the foreign establishment must designate a new one. FDA medical device U.S. Agent guidance

What success looks like

A clean switch has three outcomes: your FDA record shows the new U.S. Agent, your next renewal date is already calendared and owned, and any related registration or listing work is mapped so the same failure does not repeat.

That is the practical upgrade path FDA Entry Point describes on its site: it acts as the U.S. point of contact, relays urgent FDA communications, and tracks renewal deadlines and registration updates so coverage does not lapse. FDA Entry Point

Step 1: Confirm that you have outgrown a mailbox-only agent

Action: Audit what your current provider actually does beyond receiving FDA communications.

Expected outcome: You can separate a basic contact role from a compliance-support role and decide whether switching is a service upgrade or just a vendor swap.

Gotchas: Many providers sound full-service until you ask who owns renewals, product-listing changes, portal access, and response handling when FDA sends a time-sensitive notice.

Time estimate: 30–60 minutes.

Question to ask	Why it matters
Who tracks renewal dates and files on time?	If the answer is “you do,” the agent is not reducing the main operational risk.
Who updates FDA records when your importer, labeler, or product list changes?	Some FDA systems expect updates outside the renewal window, not just once a year or every two years.
Who receives and triages urgent FDA communications?	A forwarding inbox is not the same as a live liaison who knows what the notice means.
Who has portal access and submission history?	Switches get slower when the old provider controls the account or key records.
Who handles adjacent filings such as product listing, SPL, GUDID/UDI, label review, or Prior Notice support?	This is usually where “agent only” service breaks first.

A useful test is simple: if your current provider mainly forwards notices and leaves the filing calendar, account hygiene, and corrective work to your team, you are still carrying the compliance burden yourself. FDA Entry Point positions its service around the opposite model: point-of-contact coverage plus registration, communication handling, and renewal tracking across food, drugs, cosmetics, and devices. FDA Entry Point U.S. Agent services

Step 2: Map exactly what needs to move with the agent

Action: List every FDA record, portal, and filing cadence tied to your U.S. market access.

Expected outcome: You know whether the switch is only an agent-field update or a broader cleanup project.

Gotchas: Teams often switch the agent name but forget the linked obligations: annual device registration review, twice-yearly drug listing updates, cosmetic product listing upkeep, or food registration renewal timing.

Time estimate: 1–2 hours.

Vertical	What to map before switching	Renewal / update rhythm
Medical devices	Establishment registration, device listings, U.S. Agent field, official correspondent, GUDID/UDI responsibilities	Annual registration review between October 1 and December 31; updates can be made during the year
Drugs	Establishment registration, drug listings, SPL submission workflow, U.S. Agent details, importer information	Annual establishment renewal; listing updates in June and December if information changed
Food	Food facility registration, U.S. Agent details, importer workflow, Prior Notice process if relevant	Biennial renewal in even-numbered years, October 1 to December 31
Cosmetics	Facility registration, product listing, U.S. Agent field where applicable, Responsible Person coordination, label obligations	Facility registration renewed every two years from initial registration date; product listing updates annually

FDA’s own materials support this “map the whole record” approach. Device owners can update registration and listing information throughout the year, not only during annual review. Drug establishments that import into the U.S. must register before import, renew annually, and update listing information twice each year if it changed. Food facilities renew in even-numbered years, and cosmetics now follow their own biennial facility-renewal cycle tied to the initial registration date. FDA device registration timing, FDA importing human drugs, FDA food facility renewal guide, FDA cosmetics registration and listing

Step 3: Gather the records your new agent will need before touching FDA systems

Action: Assemble your current registration numbers, account access, product lists, importer details, and the exact legal name and address used in FDA records.

Expected outcome: Your new provider can update the agent designation without guessing or rebuilding the record from scratch.

Gotchas: The biggest delays usually come from mismatched facility names, missing account credentials, or not knowing whether the old provider is also the official correspondent or account owner.

Time estimate: Half a day to 2 business days, depending on how organized the current file is.

Current FDA registration or establishment numbers
Portal access details for the relevant system
Legal entity name and facility address exactly as filed
Current U.S. Agent name and contact details
Official correspondent details, if different
Importer information where required
Current product listings and any pending additions, discontinuations, or label changes

For devices, FDA notes that the foreign establishment may designate the U.S. Agent as official correspondent, but does not have to. That sounds minor until you switch vendors: if the old provider controls both roles, the handoff is more than a contact update. FDA device U.S. Agent guidance

Step 4: Change the U.S. Agent in the right FDA system before the next renewal deadline

Action: Update the designated U.S. Agent in the applicable FDA registration system, then confirm the new agent has accepted or verified the role where the system requires it.

Expected outcome: The new agent is active in FDA records before the next filing cycle or before another FDA communication is sent.

Gotchas: A submitted change is not always a completed change. In some systems, the new agent must affirm consent before the update is fully effective.

Time estimate: 1 business day if records are clean; longer if account access or agent confirmation is delayed.

How the mechanics differ by vertical

Medical devices: Update the U.S. Agent in FURLS/DRLM. FDA says the designated agent receives an automated email to confirm consent, and if the agent does not respond within 10 business days, the establishment must designate a new one. FDA medical device U.S. Agent guidance
Food: Update the food facility registration record in the Food Facility Registration Module. FDA guidance says changes to required registration information generally must be updated within 60 calendar days, and FDA will not confirm certain foreign-facility updates until the person identified as the U.S. Agent confirms agreement to serve. FDA food facility registration Q&A
Drugs: Make sure the establishment registration and related SPL workflow reflect the new U.S. Agent details before the next annual renewal and before the next June or December listing update if changes are pending. FDA electronic drug registration and listing instructions
Cosmetics: Update the facility registration record in Cosmetics Direct and review whether any related product-listing or Responsible Person coordination work also needs attention. FDA says facility contacts and the U.S. Agent receive automated email reminders before the facility registration renewal date. FDA cosmetics registration and listing

The practical advice is to switch before the renewal window, not during a scramble. That gives the new agent time to verify consent, test communications, and catch any stale listing or registration data while there is still room to fix it.

Step 5: Check the next renewal date and the adjacent obligations, not just the agent field

Action: Build a single renewal checklist tied to your next deadline.

Expected outcome: You avoid the common failure mode where the agent is changed but the underlying registration or listing still lapses.

Gotchas: Different verticals run on different clocks. A team that sells across categories can easily assume one renewal rule applies to all of them.

Time estimate: 30–90 minutes once the records are in hand.

Check before the next deadline	Why buyers miss it
Correct U.S. Agent is visible in the active FDA record	The update was submitted but not fully confirmed
Official correspondent and account owner are still reachable	The old vendor controlled the account setup
Facility registration is current	Teams confuse “agent changed” with “registration renewed”
Product listings are current	Listings often drift after launches, discontinuations, or label changes
Importer and contact information are current	Operational changes happen outside the renewal cycle
Any vertical-specific extras are covered	Examples include Prior Notice workflow, SPL submissions, or GUDID updates

FDA’s timing rules are not interchangeable. Device registration is reviewed annually between October 1 and December 31. Food facility renewal runs in even-numbered years during that same October-to-December window, and FDA says an unrenewed food registration expires and is removed from the account after the deadline. Cosmetic facility renewal is every two years from the initial registration date, while cosmetic product listings require annual updates. FDA device timing, FDA food renewal guide, FDA cosmetics registration and listing

Step 6: Put proactive renewal tracking in writing so the same problem does not recur

Action: Ask the new provider to document who monitors deadlines, what reminders are sent, what filings are included, and what happens when your product or facility data changes mid-cycle.

Expected outcome: You move from reactive inbox forwarding to a managed compliance calendar.

Gotchas: “We send reminders” is weaker than “we track, prepare, and file.” Buyers who were burned once usually want ownership clarified, not just better responsiveness.

Time estimate: 30 minutes during vendor selection; ongoing benefit all year.

This is where the service model matters more than the title “U.S. Agent.” FDA Entry Point says it tracks renewal deadlines and registration updates, and its category pages describe adjacent support such as food registration renewals, device listing upkeep, GUDID/UDI support, cosmetic label review, and drug-related submission support. That is the difference between replacing a contact name and replacing the operating model that failed you. FDA Entry Point food U.S. Agent services, FDA Entry Point medical device listing, FDA Entry Point cosmetic label review

Step 7: Vet the replacement agent like an operator, not like a commodity purchase

Action: Use a short diligence checklist before you sign.

Expected outcome: You avoid paying twice for the same low-service model with a different logo.

Gotchas: The cheapest providers often look interchangeable until you ask who actually does the work when something changes or goes wrong.

Time estimate: 20–30 minutes per vendor.

Who files the switch and confirms completion?
Who owns renewal tracking by vertical?
What happens if FDA sends an urgent notice outside your time zone?
Can the provider support the adjacent work your category actually needs, such as Prior Notice, product listing, SPL, GUDID/UDI, or label review?
Will you have direct human contacts, not only a generic inbox?
What records and confirmations will you receive after the switch?

For buyers who have already been burned, the strongest signal is usually operational specificity. FDA Entry Point’s public materials emphasize a human-liaison model, cross-vertical coverage, and renewal tracking rather than a bare agent-of-record role. FDA Entry Point About

Best fit and not a fit

Best fit when

You already understand the U.S. Agent requirement and want a provider that also manages the filing calendar and related compliance tasks.
You sell in one of the four verticals FDA Entry Point covers and want one relationship for agent coverage plus registration support.
You are switching because a missed renewal, buried notice, or weak response exposed a process problem, not just a pricing issue.

Not a fit when

You only want the lowest-cost mailbox service and plan to keep all renewal and registration work in-house.
Your internal regulatory team already owns every filing, every portal, and every deadline, and only needs a minimal statutory contact.